Clinical trial · Interventional
Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment
NCT03959774CI-TRIAL-00046237E-SN@P PROJECTunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
adherence of digital follow-up in a population of elderly patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IPC NET | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- breast or colorectal or lung cancer, age 70 or older
- description
- breast or colorectal or lung cancer, age 70 or older
- interventionNames
- Device: IPC NET
Primary outcomes (1)
- measure
- demonstrate that the adherence rate of digital follow-up is greater than 70% in a population of elderly patients.
- timeFrame
- 12 months after the last chemotherapy received by the patient
- description
- numerical follow-up compliance rate, defined as the rate of patients who observed the following three rules during the entire course of adjuvant chemotherapy: a minimum weight per week, the wearing of the bracelet for three consecutive days per week, and the weekly response to the digital self-questionnaire. Failure to comply with at least one of these rules will be considered a failure.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 70 years, 2. Patient with an indication of adjuvant chemotherapy showing: * Breast cancer * Colorectal cancer * lung cancer 4\. WHO ≤ 3 (WHO index - World Health Organization) 5. Estimated life expectancy\> 6 months 6. patients with a smartphone or tablet with an internet connection. It can also be offered to patients whose primary caregiver or the person of trust (including the partner) has a smartphone, an internet connection or a tablet provided that he or she is present more than three times during the week. during chemotherapy to ensure smooth weekly data transfer and filling of questionnaires 7. Signed consent to participation 8. Affiliation to, or beneficiary of, a social security scheme Exclusion Criteria: 1. Person in emergency situation, person of legal age subject to a legal protection measure (major under guardianship, guardianship or court order), or unable to express his / her consent 2. Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons 3. Contraindications to the procedure of the study: patient or caregiver living with a patient who does not have a smartphone with an internet connection (patient or caregiver living with a patient) 4. Concurrent participation in another clinical trial 5. Patient unable to understand the quality of life survey and Patient Reported Outcome
References
Publications (0)
Data not yet available
No reference posted for this study.